Prediction of Central Visual Field Measures From Macular OCT Volume Scans With Deep Learning.
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
medline:
3
11
2023
pubmed:
2
11
2023
entrez:
2
11
2023
Statut:
ppublish
Résumé
Predict central 10° global and local visual field (VF) measurements from macular optical coherence tomography (OCT) volume scans with deep learning (DL). This study included 1121 OCT volume scans and 10-2 VFs from 289 eyes (257 patients). Macular scans were used to estimate 10-2 VF mean deviation (MD), threshold sensitivities (TS), and total deviation (TD) values at 68 locations. A three-dimensional (3D) convolutional neural network based on the 3D DenseNet121 architecture was used for prediction. We compared DL predictions to those from baseline linear models. We carried out 10-fold stratified cross-validation to optimize generalizability. The performance of the DL and baseline models was compared based on correlations between ground truth and predicted VF measures and mean absolute error (MAE; ground truth - predicted values). Average (SD) MD was -9.3 (7.7) dB. Average (SD) correlations between predicted and ground truth MD and MD MAE were 0.74 (0.09) and 3.5 (0.4) dB, respectively. Estimation accuracy deteriorated with worsening MD. Average (SD) Pearson correlations between predicted and ground truth TS and MAEs for DL and baseline model were 0.71 (0.05) and 0.52 (0.05) (P < 0.001) and 6.5 (0.6) and 7.5 (0.5) dB (P < 0.001), respectively. For TD, correlation (SD) and MAE (SD) for DL and baseline models were 0.69 (0.02) and 0.48 (0.05) (P < 0.001) and 6.1 (0.5) and 7.8 (0.5) dB (P < 0.001), respectively. Macular OCT volume scans can be used to predict global central VF parameters with clinically relevant accuracy. Macular OCT imaging may be used to confirm and supplement central VF findings using deep learning.
Identifiants
pubmed: 37917086
pii: 2792982
doi: 10.1167/tvst.12.11.5
pmc: PMC10627306
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5Subventions
Organisme : NEI NIH HHS
ID : R01 EY029792
Pays : United States
Références
Sci Rep. 2020 Mar 19;10(1):5068
pubmed: 32193485
Am J Ophthalmol. 2018 Dec;196:10-17
pubmed: 30099037
Ophthalmology. 2014 Nov;121(11):2287-8
pubmed: 25156139
Am J Ophthalmol. 2019 Nov;207:18-36
pubmed: 31078529
Ophthalmology. 2020 Jul;127(7):888-900
pubmed: 32173112
Invest Ophthalmol Vis Sci. 1995 Apr;36(5):774-86
pubmed: 7706025
Ophthalmol Sci. 2021 Sep 07;1(4):100055
pubmed: 36246943
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5200-5206
pubmed: 27701631
IEEE J Biomed Health Inform. 2020 Dec;24(12):3421-3430
pubmed: 32750930
Am J Ophthalmol. 1989 Aug 15;108(2):130-5
pubmed: 2757094
JAMA. 2017 Dec 12;318(22):2211-2223
pubmed: 29234807
Transl Vis Sci Technol. 2021 Nov 1;10(13):28
pubmed: 34812893
Biomed Opt Express. 2016 Sep 15;7(10):4043-4053
pubmed: 27867714
Vision Res. 2007 Mar;47(7):925-36
pubmed: 17320924
Am J Ophthalmol. 2017 Mar;175:37-44
pubmed: 27914978
Ophthalmology. 2014 Dec;121(12):2371-9
pubmed: 25148790
Ophthalmology. 2015 Feb;122(2):293-301
pubmed: 25444345
Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):10
pubmed: 32293667
Prog Retin Eye Res. 2013 Jan;32:1-21
pubmed: 22995953
Surv Ophthalmol. 2020 Nov - Dec;65(6):597-638
pubmed: 32199939
JAMA Ophthalmol. 2020 Apr 1;138(4):333-339
pubmed: 32053142
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4815-23
pubmed: 27623336
Ophthalmology. 2005 Mar;112(3):391-400
pubmed: 15745764
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4310–4317
pubmed: 28800651
Vision Res. 2007 Oct;47(22):2901-11
pubmed: 17320143
Ophthalmology. 2022 Jul;129(7):781-791
pubmed: 35202616
Ophthalmology. 2018 Aug;125(8):1199-1206
pubmed: 29506863
Invest Ophthalmol Vis Sci. 2013 Feb 15;54(2):1345-51
pubmed: 23341012
Am J Ophthalmol. 2019 Feb;198:136-145
pubmed: 30316669
Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4646-51
pubmed: 20435603
Am J Ophthalmol. 1989 May 15;107(5):453-64
pubmed: 2712129
Br J Ophthalmol. 2019 Jun;103(6):821-825
pubmed: 30100556
Arch Ophthalmol. 2011 Dec;129(12):1529-36
pubmed: 22159673
Ophthalmology. 2020 Mar;127(3):346-356
pubmed: 31718841
Ophthalmology. 2012 Feb;119(2):308-13
pubmed: 22182800
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5477-84
pubmed: 26284553
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Sci Rep. 2018 Oct 2;8(1):14665
pubmed: 30279554
J Glaucoma. 2018 Nov;27(11):993-998
pubmed: 30180019
Ophthalmol Glaucoma. 2021 Jan-Feb;4(1):102-112
pubmed: 32826205
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4211-4217
pubmed: 28837723
Br J Ophthalmol. 2017 Aug;101(8):1052-1058
pubmed: 28077369
Ophthalmology. 2018 Dec;125(12):1907-1912
pubmed: 29934267
J Comp Neurol. 1990 Oct 1;300(1):5-25
pubmed: 2229487
Invest Ophthalmol Vis Sci. 2014 May 02;55(5):2953-62
pubmed: 24692125
Transl Vis Sci Technol. 2016 Jul 19;5(4):5
pubmed: 27486555
Prog Retin Eye Res. 2007 Nov;26(6):688-710
pubmed: 17889587
Am J Ophthalmol. 2005 Jan;139(1):44-55
pubmed: 15652827
Ophthalmology. 2020 Jun;127(6):739-747
pubmed: 31952885